UPS completes acquisition of Frigo-Trans, BPL
Deal advances end-to-end temperature-controlled logistics across Europe.
UPS announced the successful acquisition of Frigo-Trans and its sister company BPL, key European healthcare cold-chain logistics providers, known for their industry-leading expertise in temperature-controlled and time-critical transportation solutions.
The move empowers UPS Healthcare to better serve the growing demand from pharmaceutical and biotech companies for safe, efficient, and precise temperature-controlled logistics, says an official release. "Frigo-Trans' capabilities include cryopreservation (-196°C) to ambient (+15° to +25°C) storage, combined with a Pan-European cold chain transportation network. BPL complements these strengths with its time-critical freight forwarding solutions specialized for healthcare customers."
The acquisitions align with UPS Healthcare's mission to provide end-to-end logistics for temperature-sensitive healthcare products, including biologics, specialty pharmaceuticals and personalised medicine, the release added. "With 80 percent of pharmaceutical products in Europe requiring temperature-controlled transportation, investments like these ensure UPS Healthcare remains at the forefront of innovation in the $82 billion complex healthcare logistics market."
Frigo-Trans's presence in Germany - the world's fourth-largest healthcare manufacturing market —strengthens UPS's foothold and enhances its support for critical intra-Germany operations, the release added.
"Healthcare customers increasingly demand precision, reliability and adaptability - qualities that are critical for the future of biologics and personalised medicine," says John Bolla, President, UPS Healthcare. "The Frigo-Trans and BPL acquisitions allow us to offer unmatched service across Europe, making logistics a competitive advantage for our pharma partners."
UPS has consistently aimed to reshape healthcare logistics - examples include previous acquisitions of companies like Bomi and MNX. The investments are part of UPS's strategy to double healthcare revenue from $10 billion in 2023 to $20 billion by 2026, the release added.
